Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,538,832,169    

Indirect Value

   $7,608,654,183      
Total Shares   186,710,189      
Total Value   $10,147,486,352      


Neurocrine Biosciences Inc $702,928,955 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $50,832,750 Ligand Pharmaceuticals Inc $1,324,033,236 Curis Inc $3,390,252 Repligen Corp $456,592,707 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $702,928,955 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $50,832,750 Ligand Pharmaceuticals Inc $1,324,033,236 Curis Inc $3,390,252 Repligen Corp $456,592,707 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EPRS Epirus Biopharmaceuticals... Direct Beneficial Owner   –       –       •   2009-12-22 4 S $0.80 $2,542,319 D/D (3,177,899) 6,830,972 0 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-09 4 B $3.10 $66,646 D/D 21,500 2,686,609 2.45 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-10 4 B $2.79 $5,578 D/D 2,000 2,688,609 2.37 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-13 4 B $2.89 $6,361 D/D 2,200 2,690,809 2.37 -
GYRE Gyre Therapeutics Direct Beneficial Owner   –       –       •   2009-07-14 4 B $2.99 $28,492 D/D 9,516 2,700,325 2.37 -
GYRE Gyre Therapeutics Indirect Beneficial Owner   –       –       •   2009-10-16 4 S $23.60 $15,063,112 D/D (638,400) 2,061,925 0 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-07 4 B $1.41 $159,319 I/I 113,000 9,886,948 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $1.36 $270,072 I/I 198,000 10,084,948 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $1.39 $233,429 I/I 167,850 10,252,798 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $1.35 $19,571 I/I 14,511 10,267,309 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-13 4 B $1.34 $126,233 I/I 94,000 10,361,309 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-14 4 B $1.30 $273,050 I/I 210,000 10,571,309 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-17 4 B $1.33 $122,323 I/I 92,000 10,663,309 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-18 4 B $1.38 $112,536 I/I 81,400 10,744,709 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-19 4 B $1.39 $45,906 I/I 33,000 10,777,709 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-20 4 B $1.26 $11,631 I/I 9,200 10,786,909 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-21 4 B $1.78 $331,751 I/I 186,744 10,973,653 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-24 4 B $2.01 $287,573 I/I 143,000 11,116,653 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-25 4 B $1.77 $625,481 I/I 353,000 11,469,653 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-26 4 B $1.93 $2,622,922 I/I 1,350,000 12,819,653 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-28 4 B $1.99 $479,612 I/I 240,600 13,060,253 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-01 4 B $1.86 $245,476 I/I 131,700 13,191,953 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-02 4 B $1.90 $365,928 I/I 193,000 13,384,953 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-03 4 B $1.95 $54,080 I/I 27,739 13,412,692 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-04 4 B $2.04 $196,057 I/I 96,300 13,508,992 1.5 -
  195  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us